orion.fi

Project leader

 
Ari Koivisto
Principal Research Scientist, In Vitro Biology, Turku
PhD
Phone +358 50 966 7731
Fax +358 10 426 7403
E-Mail  

 

Project staff

 
Hugh Chapman
Research Scientist, In Vitro Biology, Turku
MSc
Phone +358 10 426 7455
Fax +358 10 426 7403
E-Mail  

 

 
Satu Juhila
Research Scient, In Vitro Biology, Espoo
PhD
Phone +358 50 966 5751
E-Mail  

 

 
Tuula Lähteenmäki
Research Scientist, In Vitro Biology, Espoo.
PhD
Phone +358 10 426 4574
E-Mail  

 

 
Marja Rantanen
Research Scientist, In Vitro Biology, Turku
MSc
Phone +358 10 426 7106
Fax +358 10 426 7403
E-Mail  

 

 
Kati Räsänen
Senior Scientist, In Vitro Biology,
PhD
Phone +358 50 966 7736
Fax +358 10 426 7403
E-Mail  

 

 

 
Henna Kettunen
Senior Scientist, In Vitro Biology,
M.Sc.
Phone +358 50 966 7358
Fax +358 10 426 7403
E-Mail  

 


Institute presentation

Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs.

Orion’s net sales in 2011 amounted to EUR 918 million and the company had about 3,400 employees. Orion’s A and B shares are listed on NASDAQ OMX Helsinki.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline